Cost-effectiveness of roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland

por Samyshkin, Yevgeniy, Schlunegger, Michael, Haefliger, Susan, Ledderhose, Sabine, Radford, Matthew
Publicado 2013

Cost-effectiveness of available treatment options for patients suffering from severe COPD in the UK: a fully incremental analysis

por Hertel, Nadine, Kotchie, Robert W, Samyshkin, Yevgeniy, Radford, Matthew, Humphreys, Samantha, Jameson, Kevin
Publicado 2012

Feasibility Study of a Network Meta-Analysis and Unanchored Population-Adjusted Indirect Treatment Comparison of Niraparib, Olaparib, and Bevacizumab as Maintenance Therapies in Pa...

por Lorusso, Domenica, Guy, Holly, Samyshkin, Yevgeniy, Hawkes, Carol, Estenson, Kasey, Coleman, Robert L.
Publicado 2022

Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom

por Samyshkin, Yevgeniy, Kotchie, Robert W., Mörk, Ann-Christin, Briggs, Andrew H., Bateman, Eric D.
Publicado 2013

Budget Impact of Belantamab Mafodotin (Belamaf) Adoption in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma in the United States

por Shah, Anshul, Tosh, Jonathan C, Ambavane, Apoorva, Nikolaou, Andreas, Hogea, Cosmina, Samyshkin, Yevgeniy, Gorsh, Boris, Maiese, Eric M, Wang, Feng
Publicado 2021

High levels of healthcare utilization prior to diagnosis in idiopathic pulmonary arterial hypertension support the feasibility of an early diagnosis algorithm: the SPHInX project

por Bergemann, Rito, Allsopp, James, Jenner, Harvey, Daniels, Flora Ashley, Drage, Edmund, Samyshkin, Yevgeniy, Schmitt, Claude, Wood, Steven, Kiely, David G., Lawrie, Allan
Publicado 2018